OraSure Technologies established a new relationship with Targeted Genomics and renewed an agreement with gene Dx on August 6, 2025.
1 report, 1 independent
Updated Aug 6
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
OraSure Technologies established a new relationship with Targeted Genomics and renewed an agreement with gene Dx on August 6, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
OraSure Technologies
medical device company
Nothing else this week.
Coverage
Newest first; wire copies grouped- GuruFocus.comOraSure Technologies Inc (OSUR) Q2 2025 Earnings Call Highlights: Navigating Challenges with ... Total Revenue: $31.2 million in Q2. Core Revenue: $30.8 million, excluding COVID-19 products and exite